EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical pharmacological evaluation of Butea monosperma stem bark for protective effects against experimentally-induced colonic injury in rats

Suman Mondal, Surya Mondal, Yadu Nandan Dey

Frontiers in Pharmacology · 16.11.2026 · 17

DOI: 10.3389/fphar.2026.1978829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.11.2026. Verfasst von Suman Mondal und 2 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis is a chronic inflammatory disease of the gastrointestinal tract characterized by recurrent episodes of inflammation and tissue damage, mainly affecting the colonic mucosa and submucosa. Butea monosperma stem bark has traditionally been used in Ayurveda for gastrointestinal disorders, including diarrhoea, dysentery, and Grahani Roga , which shares several features with inflammatory bowel disorders. The present study investigated the free radical scavenging, anti-inflammatory, safety, and protective effects of an aqueous extract of Butea monosperma stem bark (BME) using in vitro and in vivo approaches. Free radical scavenging activity was evaluated using DPPH and H 2 O 2 radical-scavenging assays, while anti-inflammatory activity was assessed using an albumin protein-denaturation assay. Acute oral toxicity was evaluated according to OECD 423, followed by a 28-day repeated-dose toxicity study according to OECD 407. For evaluation of protective activity, BME (100, 200, and 400 mg/kg, p.o.) or mesalamine (50 mg/kg, p.o.) was administered once daily from Day 0 to Day 14. A single intrarectal instillation of TNBS (100 mg/kg in 50% ethanol) was administered on Day 7 to induce colonic injury, and animals were euthanized on Day 14. Disease severity was assessed using relative body weight, disease activity index (DAI), colon weight-to-length ratio, colon mucosal damage index (CMDI), serum lactate dehydrogenase (LDH), tissue myeloperoxidase (MPO), thiobarbituric acid-reactive substances, and histopathology. BME exhibited concentration-dependent free radical scavenging and anti-inflammatory activities, with IC 50 values of 452.79, 5,046.13, and 1,118.04 μg/mL in the DPPH, H 2 O 2 , and protein-denaturation assays, respectively. BME showed no mortality or at 2,000 mg/kg acutely or 1,000 mg/kg for 28 days. In TNBS-induced colitis, BME, particularly at 200 and 400 mg/kg, improved relative body weight and DAI and reduced colon weight-to-length ratio and CMDI. The 400 mg/kg dose also reduced lactate dehydrogenase, myeloperoxidase, and TBARS levels and improved histopathological alterations. Overall, BME demonstrated protective effects against TNBS-induced colitis, potentially through antioxidant and anti-inflammatory mechanisms. Further molecular investigations are necessary to elucidate the underlying molecular mechanisms in greater detail.

Zitieren

APA

Mondal, S., Mondal, S., & Dey, Y. N. (2026). Preclinical pharmacological evaluation of Butea monosperma stem bark for protective effects against experimentally-induced colonic injury in rats. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1978829

Vancouver

Mondal S, Mondal S, Dey YN. Preclinical pharmacological evaluation of Butea monosperma stem bark for protective effects against experimentally-induced colonic injury in rats. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1978829

BibTeX
@article{Mondal2026,
  author = {Mondal, Suman and Mondal, Surya and Dey, Yadu Nandan},
  title = {Preclinical pharmacological evaluation of Butea monosperma stem bark for protective effects against experimentally-induced colonic injury in rats},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1978829}
}
Kostenlos starten →